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ABSTRACT : A 52-year-old man was admitted to our department for acute 
pancreatitis. He developed adult respiratory distress syndrome (ARDS) on the 2nd hospital 
day, and was treated with respiratory management using positive endexpiratory pressure 
(PEEP) in addition to pharmacologic therapy for pancreatitis. The treatment was very 
effective, and he was discharged on the 72nd hospital day.
        INTRODUCTION 
 Adult respiratory distress syndrome (ARDS) 
is a disease characterized by rapidly increas-
ing pulmonary edema, marked decrease in 
pulmonary compliance and hypoxia. It is 
associated with severe infection, trauma, burn, 
and others. Even with modern therapy its 
prognosis is grave. In our department a pa-
tient with ARDS associated with severe acute 
pancreatitis was treated with respiratory 
management using PEEP (Positive Endexpira-
tory Pressure) in addition to pharmachologic 
therapy for pancreatitis. It was very effective. 
Therefore, our case is reported here to help 
others in the management of this troublesome 
disease.
        CASE REPORT 
 A 52-year-old man, with a history of heavy 
drinking and .no history of cardiorespiratory or 
pancreatic diseases, was admitted to the Second 
Department of Internal Medicine, Oita Medi-
cal College for severe abdominal pain and 
abdominal fullness which appeared after an 
episode of binge drinking.
 Initial examination revealed a body tempera-
ture of 37.6°C and tachycardia and tachypnea 
with the pulse rate of 136/min. and the 
respiratory rate of 40/min.. 
 Cardiorespiratory examinations were normal. 
The abdomen was markedly distended and 
tympanic, with an abscence of bowel sound and 
no evidence of ascites. There was severe diffuse 
abdominal tenderness with guarding, particu-
larly in the upper quadrants, but there was no 
rebound tenderness. 
 Admission laboratory data (normal values in 
parentheses) revealed the white blood cell count 
of 16,800 cells/mm (2950-8970), hemoglobin of 
18.8g/dl (13.6-17.3), a hematocrit of 56.5% (41.2-
52.9), and platelet count of 87,000/mm (136,000-
323,000). The serum protein was 5.8g/dl (6.3-7.9), 
the serum bilirubin was 1.7mg/dl (0.1-1.1), the 
SGOT was 123 IU/l (11-36), the SGPT was 71 
IU/l (2-34) and the lactate dehydrogenase was 
2228 IU/ 1(212-410). The serum amylase was 269 
U/l (52-150) consisting of 97.9% pancreatic and 
2.0% salivary isozymes, the elastase 1 was 
1497ng/dl (under 400), the lipase was 280 IU/l 
(10-150), the PSTI was 375ng/ml (5.9-22.7)' and 
the CA19-9 was 145 U/ml (under 37). The Blood 
urea nitrogen was 38mg/dl (8-21), the serum 
creatinine was 4.4mg/dl (0.7-1.3) and the serum
electrolyte included a calcium of 7.7mg/dI (8.2-
10.2), a sodium of 129.OmEq/1 (136-152) and 
potassium of 6.7mEq/ 1 (3.5-5.3). The phosphorus 
and chloride were within normal limits. The 
serum C-reactive protein was 54.5mg/dl (under 
0.3). Arterial blood gas analysis demonstrated 
a mild hypoxemia with the pH of 7.410, P02 of 
64.8mmHg, PCO2 of 27mmHg and oxygen 
saturation of 93.2%. 
 A chest X-ray film on admission showed no 
evidence of pulmonary edema, although ate-
lectasis was noted due to inspiratory insuffi-
ciency (Fig. 1). The portable KUB film revealed 
marked small bowel gas (Fig. 2). 
 At the time of admission, the urine output 
was 10 ml/hour because of severe dehydra-
tion. Saline solution was administered rapidly 
at 1000m1 per hour for 5 hours, with subsequent 
urine output of 100-150ml/hour and improve-
ment of blood urea nitrogen and creatinine by 
the 7th hospital day. On the 2nd hospital day, 
rhonchi was auscultated, and a chest X-ray 
film revealed infiltrative shadows in both lung 
fields (Fig. 3). The patient was treated with 
oxygen administered at 121/min. by mask, but 
hypoxemia was aggravated with a pH of 7.355, 
P02 of 60.7mmHg, PCO2 of 36.4mmHg and 
oxygen saturation of 90.4%. ARDS associated 
with acute pancreatitis was suggestged. A 
naso-endotracheal intubation was performed 
and oxygen was administered with controlled
Fig. 2 Portable KUB film revealing marked small 
      bowel gas.
Fig. 3 Two days after admission, chest X-ray film 
      revealed infiltrative shadows in both lung 
      fields.
Fig. 1 Portable chest X-ray on admission showing 
       no evidence of pulmonary edema.
respiration, but there was no improvement in 
arterial blood gas with a pH of 7.159, P02 of 
53.lmmHg and PCO2 of 69.OmmHg. A 
Swan-Ganz catheter was inserted and revealed 
normal pulmonary capillary wedge pressure and 
cardiac index, confirming the diagnosis of 
ARDS. He was treated with PEEP followed by 
an excellent response. The arterial blood gas 
improved with a pH of 7.258, P02 of 74.1mmHg 
and PCO2 of 52.8mmHg. Subsequently there was 
subjective and objective improvement in his 
condition. He was removed from the respirater
on the 7th hospital day and extubated on the 
next day. 
 The therapy with methyl predonisolone was 
started from the 1st hospital day. For the first 
three days it was administered in the doses of 
1000mg per day, and for the next three days in 
the doses of 40mg per day. At the same time, 
the therapy for acute pancreatitis included 
fasting bowel rest, and intravenous gabexate 
mesilate, urinastatin and citicoline. The ab-
dominal pain disappeared on the 6th hospital 
day. On the 49th hospital day, all laboratory 
values returned to normal and the patient was 
discharged on the 72nd hospital day.
          DISCUSSION 
 For patients with acute pancreatitis, respi-
ratory complications are very important prog-
nostic factors, Sixty per cent of deaths from 
acute pancreatitis occur within the first 7 days 
of illness and are associated with acute respi-
ratory failures'. Pitchumoni et al. enumerated 
three groups of pulmonary complications of 
acute pancreatitis. The first is early arterial 
hypoxia. The second group consists of 
atelectasis, pneumonia, pleural effusion and 
mediastinal abscess. The third is ARDS2'. 
ARDS was reported in 1967 by Ashbaugh et alL 
as a grave disease characterized by rapidly 
increasing respiratory failure, pulmonary ede-
ma, marked decrease in pulmonary compli-
ance and hypoxia3'. 
 Recently it is known as a syndrome with 
severe hypoxia, diffuse infiltrative shadows in 
both lung fields, normal pulmonary capillary 
wedge pressure and low pulmonary compliance. 
It frequently complicates severe infections, 
trauma or burns'-". The frequency of ARDS 
complicating inpatients with severe disease is 
about 25%7', and the mortality rate is between 
40 and 60 %8'. 
 Acute pancreatitis with ARDS, first described 
in 1972 by Interiano et al., is seen in 20% of 
patients with acute pancreatitis9'. There are 
some pathogenetic theories of ARDS in acute 
pancreatitis, but they are controversial and 
unclear2'. 
 The kinin system, activated by active trypsin, 
may injure pulmonary vessels, or active trypsin
may initiate intravascular coagulation with 
fibrin microemboli involving the pulmonary 
microcirculation10'. Elevated levels of phospho-
lipase (lecithinase) have been noted in acute 
pancreatitis. Increased degradation of lecithin 
by elevated lecithinase concentrations may be 
responsible for alveolar collapse in acute 
pancreatitis2'. 
 Salil et alL studied ARDS associated with acute 
pancreatitis in adult mongrel dogs and sug-
gested the following mechanism. Macro-
phages may accumulate and secrete more 
phospholipase A2 in the alveoli. The activity 
of phospholipase A2 causes a reduction in the 
recovery of usefull surfactant and an increase 
in the level of lysolecithin which may act as an 
anti-surfactant or cellular toxin and be 
responsible for the development of interstitial 
alveolar edema and subsequent pulmonary 
distress"' 
 Unbound FFA can be toxic. In acute 
pancreatitis, pulmonary lipoprotein lipase, 
activated by an unknown pancreatic factor, 
causes local release of FFA from triglycerides, 
and these unbound FFA then injure the 
capillary alveolar membrane2, 12, 
 Recently, neutrophils, macrophages, metabo-
lites of arachidonic acid such as prostaglandin 
E2 or thromboxane A2, or fibrin and fibrin 
degradation products have been considered as 
the pathogenetic facters in ARDS. Neutrophils 
are particularly important and the following 
pathogenetic theory starts with stress causing 
neutrophil aggregation and stasis in pulmonary 
capillaries generated by C5a. Activated neutro-
phil produces oxygen free radical, metabolites 
of arachidonic acid or protease. These prod-
ucts injure pulmonary capillary endothelial 
cells, with a resultant increase in pulmonary 
endothelial permeability. Consequently, inter-
stitial and alveolar edema, increased pulmonary 
shunt and decreased PaO are caused. At the 
same time, the bronchus becomes constricted, 
with decreased pulmonary compliance and 
tachypnea13-"> 
 ARDS is treated with various therapies in 
addition to the treatment of the primary disease. 
Fluid therapy, oxygen therapy, the use of 
corticosteroid or diuretics and prophylaxis 
against DIC are performed as indicated').
 Fluid therapy improves oliguria due to 
dehydration or shock. In this patient a large 
amount of intravenous infusion over a short 
time improved oliguria due to dehydration. 
However, excess fluid therapy is injurious to the 
respiratory function and monitoring of pul-
monary capillary wedge pressure using a Swan-
Ganz catheter is necessary". 
 In ARDS, shunt formation due to stasis causes 
hypoxia which is not responsive to oxygen 
therapy. As high concentrations of oxygen 
cause an increase in alveolar epithelial or 
pulmonary endothelial permeability"', PEEP is 
used in order to raise PaO2 using an oxygen 
concentration which will not cause oxygen 
toxicity. When using PEEP, assisted ventillation 
may not be necessary, unless hypoventilation 
or advanced pulmonary edema raises the CO2 
level, in which case ventilatory assistance 
should be promptly initiated. In this case, nasal 
cannula, mask, tent and endotracheal intubation 
with assisted ventilation were not effective in 
normalizing Pa02, but the use of PEEP nor-
malized oxygenation. 
 Usually, corticosteroids have been used in an 
attempt to prevent endothelial damage, as they 
inhibit the action of phospholipases20'. This 
patient was given high dose corticosteroids in 
the short period after admission, but its effect 
is unclear. Recently, steroids have been used 
only in the early treatment of fat embolism, 
smoke inhalation or chemical pneumonia, 
because there is no evidence of their beneficial 
effects in ARDS, after the appearance of 
symptomes. Usually methyl predonisolone, 
30mg/kg every 12 or 24 hours, is given in-
travenously l or 2 times." 
 In our department, 18 cases of acute pan-
creatitis have been experienced from 1982. 
Three cases were severe and 2 cases, including 
this case, were associated with pulmonary com-
plications (ARDS and pleural effusion). The 
frequency of ARDS in severe acute pancreatitis 
is relatively high, and precise diagnosis and 
agressive respiratory management are neces-
sary.
         REFERENCES 
1) Renner, I. G., Savage, W. T., Pantoja, J. L. and 
   Renner, V. J.: Death due to acute pancreatitis : 
   a retrospective analysis of 405 autopsy cases. 
  Dig. Dis. Sci. 30: 1005-1018 (1985). 
2) Pitchumoni, C. S., Agarwal, N. and Jain, N. K.: 
   Systemic complications of acute pancreatitis. 
   Am. J. Gastroenterol. 83: 597-606 (1988). 
3) Ashbaugh, D. G., Bigelow, D. B., Petty, T. L. and 
   Levine, B. E.: Acute respiratory distress in 
   adults. Lancet. II : 319-323 (1967). 
4) Pontoppidan, H., Geffin, B. and Lowenstein, E.: 
   Acute respiratory failure in the adults.: N. Eng. 
  J. Med. 289: 690-698 (1972). 
5) Petty, T. L.: Adult respiratory distress syn-
   drome : Definition and historical perspective. 
   Clin. Chest. Med. 3: 3-7 (1982). 
6) Hopewell, P. and Murray, J. F.: The adult 
   respiratory distress syndrome. Ann. Rev. Med. 
  27: 343-356 (1976). 
7) Sharma, O. P. and Izumi, T.: ARDS. They. Res. 
  8: 623-633 (1988). 
8) Raffin, T. A.: Novel approches to ARDS and 
   sepsis. In : Chernow, B. and Shoemaker, W. C., 
   eds. Critical care state of art, vol. 7. The Society 
  of Critical Care Medicine.: 247-280 (1986). 
9) Interiano, B., Stuard, I. D. and Hyde, R. W.: 
   Acute respiratory distress syndrome in pan-
   creatitis. Ann. Intern. Med. 77: 923-926 (1972). 
10) Berry, A. R., Taylor, T. V. and Davies, G. C.: 
   Pulmonary function and fibrinogen metabolism
   in acute pancreatitis. Br. J. Surg. 68: 870-873 
  (1981). 
11) Salil, K. D., Mack, T. S. and Stonewall, M. C.: 
   Effects of experimental acute pancreatitis in 
   dogs on metabolism of lung surfactant phos-
   phatidylcholine. Biochem. Biophys. Res. Com-
   m u n. 145: 612-618 (1987). 
12) Kimura, T., Toung, J. K. and Margolis, S.: 
   Respiratory failure in acute pancreatitis : The 
  role of free fatty acids. Surgery 87 : 509-513 (1980). 
13) Tate, R. M. and Repine, J. E.: Neutrophils and 
   adult respiratory distress syndrome. Am. Rev. 
  Respir. Dis. 125: 522-559 (1983). 
14) Mc Cord, J. M.: Oxygen radicals and lung injury: 
  The state of the art. Chest 85: 35s (1983). 
15) Hammerschmidt, D. E.: Leukocytes in lung 
  injury. Chest 85 : 16s (1983). 
16) Till, G. 0., Johnson, K. J., Kunkel, R. and Ward, 
   P. A.: Intravascular activation of complement 
   and acute lung injury dependency on neu-
   trophils and toxic oxygen metabolites. J. Clin. 
  Invest. 69: 1126-1135 (1982).
17) Cochrane, C. G. , Spragg, R. G. and Revak, S. 
   D.: The presence of neutrophil elastase and
   evidence of oxidation activity in bronchoalveolar 
   lavage fluid of patients with adult respiratory 
   distress syndrome. Am. Rev. Respir. Dis. 127: 27s 
  (1983). 
18) Tate, R. M. and Repine, J. E.: Oxygen radicals 
   cause pulmonary edema and vasoconstriction in 
  isolated salt perfused rabbit lungs. Clin. 
  Research 30: 75A (1982).
19) Denker, S. M. and Fanburg, B. L.: Oxygen 
   toxicity of the lung: An update. Br. J. Anaesth. 
  54: 737-749 (1982). 
20) Replogle, R. L., Guzzaniga, A. B. and Gross, R. 
   E.: Use of corticosteroids during cardio-
   pulmonary bypass. Possible lysosomal stabiliza-
  tion. Circulation 33: 86-92 (1966).
